These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9834742)

  • 61. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of hyperfunctional lines of the face with botulinum toxin A.
    Binder WJ; Blitzer A; Brin MF
    Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ten Mistakes To Avoid When Injecting Botulinum Toxin.
    Ruiz-Rodriguez R; Martin-Gorgojo A
    Actas Dermosifiliogr; 2015; 106(6):458-64. PubMed ID: 25956528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Botulinum toxin below the eyes.
    Carruthers J; Carruthers A
    Int Ophthalmol Clin; 2005; 45(3):133-41. PubMed ID: 15970772
    [No Abstract]   [Full Text] [Related]  

  • 65. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.
    Dayan SH; Arkins JP; Patel AB; Gal TJ
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of clostridium botulinum: a neurotoxin in clinical dermatology.
    Matarasso SL
    West J Med; 1998 Oct; 169(4):226. PubMed ID: 9795588
    [No Abstract]   [Full Text] [Related]  

  • 70. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.
    Garcia A; Fulton JE
    Dermatol Surg; 1996 Jan; 22(1):39-43. PubMed ID: 8556256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area.
    Mazzuco R; Hexsel D
    J Am Acad Dermatol; 2010 Dec; 63(6):1042-51. PubMed ID: 21093661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
    Iozzo I; Tengattini V; Antonucci VA
    J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-Term Cumulative Effects of Repeated Botulinum Toxin Type A Injections on Brow Position.
    Hexsel D; Dal'Forno T; Hexsel C; OliveiraCamozzato F
    Dermatol Surg; 2020 Sep; 46(9):1252-1254. PubMed ID: 31517662
    [No Abstract]   [Full Text] [Related]  

  • 74. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Botulinum toxin A in the mid and lower face and neck.
    Carruthers J; Carruthers A
    Dermatol Clin; 2004 Apr; 22(2):151-8. PubMed ID: 15222575
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents.
    Mandeville JT; Rubin PA
    Int Ophthalmol Clin; 2004; 44(1):189-212. PubMed ID: 14704531
    [No Abstract]   [Full Text] [Related]  

  • 77. Botulinum toxin A: a novel method to remove periorbital wrinkles.
    Keen M; Kopelman JE; Aviv JE; Binder W; Brin M; Blitzer A
    Facial Plast Surg; 1994 Apr; 10(2):141-6. PubMed ID: 7995530
    [No Abstract]   [Full Text] [Related]  

  • 78. [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].
    Laskawi R; Rohrbach S
    Laryngorhinootologie; 2001 Dec; 80(12):708-13. PubMed ID: 11793266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L; Jun T; Bo P; Bosheng Z; Qian Z; Dongping L
    J Plast Reconstr Aesthet Surg; 2010 Dec; 63(12):2026-31. PubMed ID: 20116356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.